최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기예방의학회지 = Korean journal of preventive medicine, v.36 no.4, 2003년, pp.339 - 348
이후연 (연세의대 예방의학교실, 연세대 보건정책 및 관리연구소) , 박은철 (연세의대 예방의학교실, 연세대 보건정책 및 관리연구소, 연세대 보건대학원) , 박기동 (보건복지부 국립보건원 전염병관리부 방역과) , 박지은 (연세대 보건정책 및 관리연구소) , 김영 (사이넥스 컨설팅) , 이상수 (한국존슨앤존슨메디칼) , 강혜영 (연세대 보건정책 및 관리연구소, 연세대 보건대학원)
Objective : To quantify the economic value of the Sirolimus fluting Stent (
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Detels R, Breslow L. Current scope and concerns in public health. In: Oxford textbook of public health. 4th ed. Oxford University Press; 2002
Glagov S, Weisenberg E, Zarins CK, Stankynavicius R, Kloettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. New England J Med 1987; 316: 1371-1375
National Heart, Lung, and Blood Institute. Morbidity and mortality: 1998 chartbook on cardiovascular, lung, and blood disease. National Institute of Health; 1998
사망원인 통계연보. 통계청; 2001
Gil R, Di Mario C, Prati F, von Birgelen C, Ruygrok P, Roelandt JR, Serruys PW. Influence of plaque composition on mechanisms of percutaneous transluminal coronary balloon angioplasty assessedby ultrasound imaging. AHJ 1996; 131: 591-597
Di Sciascio G, Patti G, Nasso G, Manzoli A, D' Ambrosio A, Abbate A. Early and long-term results of stenting of diffuse coronary artery disease. Am J Cardiol 2000;86(11): 1166-1170
lijima R, Nakamura M, Kitagawa Y. Comparison of the efficacy of cutting balloon and balloon angioplasty for highrisk in-stent restenosis. Am J Cardiol 2000; 86(8A): 12 li
Schofer J, Schluter M, Rau T, Hammer F, Haag N, Detlef G. Mathey DG. Influence of treatment modality on angiographic outcome after coronary stenting in diabetic patients: a controlled study. JACC 2000; 35(6): 1554-1559
Zidar J, Fry E, Lambert C. The VENUS trial: a multi-centre registry of the Cordis $Bx^{TM}$ -stent platform. Am J Cardiol 2000; 86(8A): 17i
Betriu A, Masotti M, Serra A, Alonso J, Fernandez-Aviles F, Gimeno F, Colman T, Zueco J, Delean JL, Garda E, Jose Calabuig J. Randomised comparison of coronary stent implantation and balloon angioplasty in the treatment of de novo coronary artery lesions. JACC 1999; 34: 1498-1506
Chaitman BR, Rosen AD, Williams DO, Bourassa MG, Aguirre FV, Pitt B, Rautaharju PM, Rogers WJ, Sharaf B, Attubato M, Hardison RM, Srivatsa S, Kouchoukos NT, Stocke K, Sopko G, DetreK, FryeR. Myocardial infarction and cardiac mortality in the bypass angioplasty revascularization investigation (BARI) randomized trial. Circulation 1997; 96: 2162-2170
Hospital Episode Statistics. 1999/00 Key Facts and Figures. Department of Health and Human Service; 2001
한국심장재단 . 2001년 전국 심장혈관질환 수술현황 http://www.heart.or.kr
Altman JD, Bayes-Genis A, Schwartz RS. Pathophysiology of restenosis in Restenosis: a Guideto Therapy. Ed. FaxonDP, Martin Dunitz Ltd,London; 2001
Suzuki T, Kopia GA, Hayashi S, Bailey LR, Llanos G, Wilensky R, Klugherz BD, Papandreou G, Narayan P, Leon MB, Yeung AC, Tio F, Tsao PS, Falotico R, Carter AJ. Stent-based delivery of sirolimus reduces neointirnal formation in a porcine coronary model. Circulation 2001; 104: 1188-1193
Poon M, Marx SO, Gallo R, Badimon JJ, Taubman MB, Marks AR. Rapamycin inhibits vascular smooth muscle cell migration. J. Clin. Invest. 1996;98(10): 2277-2283
Gregory CR, Huang X, Pratt RE. Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement. Transplantation 1995; 59(5): 655-661
Marx SO, Jayaraman T, Go LO, Marks AR. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smoothmuscle cells. Circ. Res. 1995; 76: 412-417
Serruys PW, Morice MC, Sousa JE. The RAVEL study: a randomized study with the sirolimus coated Bx velocity balloonexpandable stentin the treatment of patients withde novo native coronary arterylesions. Eur Heart J 2001; 22(suppl): 2624
Sousa JE, Costa MA, Abizaid A, Abizaid AS, Feres F, Pinto IMF, Seixas AC, Staico R, Mattos LA, Sousa AGMR, Falotico R, Jaeger J, Popma JJ, Serruys PW. Lack of neointimal proliferation after implantation of sirolimus coated stents in human coronary arteries, Circulation 2001; 103: 192-195
Sousa JE, Costa MA, Abizaid A. Mid(4month) and long-terrn(1-year) QCA and three dimensional IVUS follow-up after implantation of sirolimus-coated stent in human coronary arteries. JACC 2001; 37(2): 29-32
Carter AJ, Bailey LR, Llanos G. Stent basedsirolimus delivery reduces neointirnal proliferation in a porcine coronary model of restenosis. JACC 2000; 35: 1041-1085
Klugherz BD, Llanos G, Kopia GA . Intramural kinetics of sirolimus elutedfrom an intracoronary stent. Circulation 2000; 102(18): 35-44
Lamotte M, Annemans L. A decision analytic model to evaluate the health economic value of the sirolimus-eluting stent( $CYPHER^{TM}$ ) in acute coronary artery disease. HEDM; 2002
Serruys PW, van Hout B, Bonnier H, Legrand V, Garcia E, Macaya C, Sousa E, Giessen WVD,Colombo A, Seabra-Gomes R, Kiemeneij F, Ruygrok P, Ormiston J, Emanuelsson H, Fajadet J, Haude M, Klugmann S, Morel MA, the Benestent Study Group. Randomized comparison of implantation of heparin coated stents with balloon angioplasty in selected patients with coronary artery clisease (Benestent II).Lancet 1998;352(9192): 673-681
Morice MC. A Randomized double-blind study with the Sirolimus-eluting Bx $Velocity^{TM}$ balloon expandable stent in the treatment of patients with de novo native coronary artery Lesions. ESC congress Stockholm; 2001
Kiemeneij F, Serruys PW, Macaya C, Rutsch W, Heyndrickx G, Albertsson FajadetJ, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy JJ, Disco CMC, Morel MA, Benestent I Study Group. Continued benefit of coronary stenting versus balloon angioplasty: five year follow-up of Benestent-I trial. J Am Call Cardiol 2001; 37(6): 1598-1603
Hlatky MA, Rogers WJ, Johnstone I, Boothroyd D, Brooks MM, Pitt B, Reeder G, RyanT, SmithH, Whitlow P, Wiens R, Mark DB, Rosen AD, Detre K, Frye RL, The BypassAngioplasty Revascularization Investigation (BARI) Investigators. Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. Bypass Angioplasty Revascularization Investigation(BARI) Investigators. N Eng J Med 1997; 336(2): 92-99
건강보험심사통계연보. 건강보험심사평가원; 2000
Petitti DB. Meta-analysis, decision analysis and cost-effectiveness analysis. New York, Oxford, Oxford University Press; 1994
Park SJ, Shim WH, Ho DS, Raizner AE, Park SW, Hong MK, Lee CW, Choi DC, Jang YS, Lam RL, Weissman NJ, Mintz GS. A Placitaxel-eluting stenting for the prevention of coronary restenosis. N Engl J Med2003; 348: 1537-1545
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.